Shao‐Lan Qin

724 total citations
26 papers, 482 citations indexed

About

Shao‐Lan Qin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shao‐Lan Qin has authored 26 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Shao‐Lan Qin's work include Cancer, Hypoxia, and Metabolism (4 papers), Colorectal Cancer Surgical Treatments (4 papers) and MicroRNA in disease regulation (4 papers). Shao‐Lan Qin is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Colorectal Cancer Surgical Treatments (4 papers) and MicroRNA in disease regulation (4 papers). Shao‐Lan Qin collaborates with scholars based in China, Nepal and United States. Shao‐Lan Qin's co-authors include Ming Zhong, Yang Luo, Yifei Mu, Minhao Yu, Qi Yang, Zhengshi Wang, Ran Cui, Jun Qin, Guangyao Ye and Yan Zhang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Medicine and The International Journal of Biochemistry & Cell Biology.

In The Last Decade

Shao‐Lan Qin

26 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shao‐Lan Qin China 13 269 179 140 93 53 26 482
Snahlata Singh India 11 246 0.9× 205 1.1× 148 1.1× 103 1.1× 50 0.9× 14 468
Zhuqing Zhou China 14 329 1.2× 150 0.8× 205 1.5× 66 0.7× 97 1.8× 26 529
Weiyu Ge China 9 324 1.2× 173 1.0× 181 1.3× 79 0.8× 64 1.2× 20 502
Nicole P. Ho Hong Kong 6 265 1.0× 137 0.8× 213 1.5× 65 0.7× 46 0.9× 9 453
Marco Zanotto Italy 9 221 0.8× 254 1.4× 118 0.8× 134 1.4× 85 1.6× 13 489
Ying-Hui Zhu China 11 290 1.1× 129 0.7× 131 0.9× 51 0.5× 50 0.9× 15 422
Na Zhou China 14 266 1.0× 156 0.9× 223 1.6× 99 1.1× 55 1.0× 33 488
Alexander Hamm Germany 5 209 0.8× 116 0.6× 91 0.7× 88 0.9× 44 0.8× 9 385
Xuanfu Xu China 13 367 1.4× 161 0.9× 156 1.1× 64 0.7× 36 0.7× 19 499

Countries citing papers authored by Shao‐Lan Qin

Since Specialization
Citations

This map shows the geographic impact of Shao‐Lan Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shao‐Lan Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shao‐Lan Qin more than expected).

Fields of papers citing papers by Shao‐Lan Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shao‐Lan Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shao‐Lan Qin. The network helps show where Shao‐Lan Qin may publish in the future.

Co-authorship network of co-authors of Shao‐Lan Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Shao‐Lan Qin. A scholar is included among the top collaborators of Shao‐Lan Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shao‐Lan Qin. Shao‐Lan Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Luo, Yang, Minhao Yu, Yizhou Huang, et al.. (2021). Lymphadenectomy Around Inferior Mesenteric Artery in Low-Tie vs High-Tie Laparoscopic Anterior Resection: Short- and Long-Term Outcome of a Cohort of 614 Rectal Cancers. Cancer Management and Research. Volume 13. 3963–3971. 9 indexed citations
3.
Qin, Shao‐Lan, Yang Luo, Yizhou Huang, et al.. (2021). AIM2 Inhibits BRAF-Mutant Colorectal Cancer Growth in a Caspase-1-Dependent Manner. Frontiers in Cell and Developmental Biology. 9. 588278–588278. 9 indexed citations
4.
Luo, Yang, Minhao Yu, Yong Zhou, et al.. (2020). Rab27A promotes cellular apoptosis and ROS production by regulating the miRNA‐124‐3p/STAT3/RelA signalling pathway in ulcerative colitis. Journal of Cellular and Molecular Medicine. 24(19). 11330–11342. 27 indexed citations
5.
Yu, Minhao, Ran Cui, Yizhou Huang, et al.. (2019). Increased proton-sensing receptor GPR4 signalling promotes colorectal cancer progression by activating the hippo pathway. EBioMedicine. 48. 264–276. 34 indexed citations
6.
Yu, Minhao, Ran Cui, Yizhou Huang, et al.. (2019). Increased Proton-Sensing Receptor GPR4 Signaling Promotes Colorectal Cancer Progression by Activating the Hippo Pathway. SSRN Electronic Journal. 10 indexed citations
7.
Cao, Dongxing, Yang Luo, Shao‐Lan Qin, et al.. (2019). Metallopanstimulin-1 (MPS-1) mediates the promotion effect of leptin on colorectal cancer through activation of JNK/c-Jun signaling pathway. Cell Death and Disease. 10(9). 655–655. 16 indexed citations
8.
Qin, Shao‐Lan, Yong Zhou, Jianjun Chen, et al.. (2018). Low levels of TSC22 enhance tumorigenesis by inducing cell proliferation in colorectal cancer. Biochemical and Biophysical Research Communications. 497(4). 1062–1067. 3 indexed citations
9.
Luo, Yang, Shao‐Lan Qin, Yifei Mu, et al.. (2018). Increased epoxyeicosatrienoic acids may be part of a protective mechanism in human ulcerative colitis, with increased CYP2J2 and reduced soluble epoxide hydrolase expression. Prostaglandins & Other Lipid Mediators. 136. 9–14. 10 indexed citations
10.
Chen, Jianjun, Yang Luo, Yong Zhou, et al.. (2018). Promotion of Tumor Growth by ADAMTS4 in Colorectal Cancer: Focused on Macrophages. Cellular Physiology and Biochemistry. 46(4). 1693–1703. 22 indexed citations
11.
Cao, Dongxing, Shao‐Lan Qin, Yifei Mu, & Ming Zhong. (2017). The role of MRP1 in the multidrug resistance of colorectal cancer. Oncology Letters. 13(4). 2471–2476. 27 indexed citations
13.
Zhang, Yan, Yang Luo, Shao‐Lan Qin, et al.. (2016). The clinical impact of ICOS signal in colorectal cancer patients. OncoImmunology. 5(5). e1141857–e1141857. 68 indexed citations
14.
Luo, Yang, Guangyao Ye, Shao‐Lan Qin, et al.. (2016). High expression of Rab3D predicts poor prognosis and associates with tumor progression in colorectal cancer. The International Journal of Biochemistry & Cell Biology. 75. 53–62. 34 indexed citations
15.
Guo, Feng, Yang Luo, Yifei Mu, et al.. (2016). miR-193b directly targets STMN1 and inhibits the malignant phenotype in colorectal cancer.. PubMed. 6(11). 2463–2475. 29 indexed citations
16.
Wang, Zhengshi, Ming Zhong, Yuhai Bian, et al.. (2016). MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer. Oncotarget. 7(28). 44266–44276. 31 indexed citations
17.
Luo, Yang, et al.. (2015). Elevated expression of ECT2 predicts unfavorable prognosis in patients with colorectal cancer. Biomedicine & Pharmacotherapy. 73. 135–139. 17 indexed citations
18.
Luo, Yang, Shao‐Lan Qin, Minhao Yu, et al.. (2015). Prognostic value of regulator of G-protein signaling 6 in colorectal cancer. Biomedicine & Pharmacotherapy. 76. 147–152. 11 indexed citations
19.
Ye, Guangyao, Minhao Yu, Zhengshi Wang, et al.. (2015). [Impact of lysosome-associated protein transmembrane-4 beta on proliferation and invasion of colorectal cancer].. PubMed. 18(6). 606–10. 1 indexed citations
20.
Yu, Minhao, Yang Luo, Shao‐Lan Qin, & Ming Zhong. (2015). Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients.. PubMed. 8(6). 6974–80. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026